{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T23:19:59Z","timestamp":1770592799828,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2989,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/mt.2008.119","type":"journal-article","created":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T10:37:29Z","timestamp":1212575849000},"page":"1459-1466","source":"Crossref","is-referenced-by-count":45,"title":["Targeting of the CNS in MPS-IH Using a Nonviral Transferrin-\u03b1-l-iduronidase Fusion Gene Product"],"prefix":"10.1016","volume":"16","author":[{"given":"Mark J","family":"Osborn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron T","family":"McElmurry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Tolar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce R","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2008.119_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1038\/mt.2008.119_bib2","first-page":"381","article-title":"The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment","volume":"7","author":"Hopwood","year":"1990","journal-title":"Mol Biol Med"},{"key":"10.1038\/mt.2008.119_bib3","first-page":"251","article-title":"Communicating hydrocephalus in children with genetic inborn errors of metabolism","volume":"1","author":"Fowler","year":"1975","journal-title":"Childs Brain"},{"key":"10.1038\/mt.2008.119_bib4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0090-3019(82)80004-9","article-title":"Cervical myelopathy due to dural compression in mucopolysaccharidosis","volume":"17","author":"Kaufman","year":"1982","journal-title":"Surg Neurol"},{"key":"10.1038\/mt.2008.119_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1469-8749.1973.tb15160.x","article-title":"Cervical cord compression in mucopolysaccharidosis","volume":"15","author":"Kennedy","year":"1973","journal-title":"Dev Med Child Neurol"},{"key":"10.1038\/mt.2008.119_bib6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3171\/jns.1974.41.5.0618","article-title":"Spinal pachymeningitis secondary to mucopolysaccharidosis. Case report","volume":"41","author":"Paulson","year":"1974","journal-title":"J Neurosurg"},{"key":"10.1038\/mt.2008.119_bib7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s004310050904","article-title":"Cerebrospinal fluid shunts in the management of behavioural problems in Sanfilippo syndrome (MPS III)","volume":"157","author":"Robertson","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1038\/mt.2008.119_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-3101(24)00309-8","article-title":"Mucopolysaccharidoses","volume":"33","author":"Muenzer","year":"1986","journal-title":"Adv Pediatr"},{"key":"10.1038\/mt.2008.119_bib9","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","article-title":"Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome","volume":"87","author":"Peters","year":"1996","journal-title":"Blood"},{"key":"10.1038\/mt.2008.119_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/13543784.11.5.675","article-title":"Enzyme replacement therapy for the mucopolysaccharide storage disorders","volume":"11","author":"Kakkis","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1038\/mt.2008.119_bib11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2008.119_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0963-6897(95)00021-O","article-title":"Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases","volume":"4","author":"Krivit","year":"1995","journal-title":"Cell Transplant"},{"key":"10.1038\/mt.2008.119_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2008.119_bib14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s10545-006-0457-y","article-title":"Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome","volume":"29","author":"Thomas","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2008.119_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00431-006-0316-8","article-title":"Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I","volume":"166","author":"Tokic","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1038\/mt.2008.119_bib16","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00006123-199805000-00082","article-title":"Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means","volume":"42","author":"Kroll","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1038\/mt.2008.119_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1038\/mt.2008.119_bib18","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0702170104","article-title":"Targeted delivery of proteins across the blood-brain barrier","volume":"104","author":"Spencer","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.119_bib19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/jpet.104.082974","article-title":"Delivery of \u03b2-galactosidase to mouse brain via the blood-brain barrier transferrin receptor","volume":"313","author":"Zhang","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/mt.2008.119_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ymthe.2005.04.013","article-title":"A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system","volume":"12","author":"Osborn","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.119_bib21","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1089\/10430349950017734","article-title":"High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA","volume":"10","author":"Zhang","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2008.119_bib22","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.119_bib23","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1471-4159.1990.tb04886.x","article-title":"Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins","volume":"54","author":"Triguero","year":"1990","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2008.119_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human \u03b1-l-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J Pediatr"},{"key":"10.1038\/mt.2008.119_bib25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2174\/092986707780597943","article-title":"Molecular anatomy of the brain endothelial barrier: an overview of the distributional features","volume":"14","author":"Ueno","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1038\/mt.2008.119_bib26","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1073\/pnas.0308728100","article-title":"Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice","volume":"101","author":"LeBowitz","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.119_bib27","doi-asserted-by":"crossref","first-page":"35037","DOI":"10.1074\/jbc.M402630200","article-title":"Lipoprotein receptor binding, cellular uptake, and lysosomal delivery of fusions between the receptor-associated protein (RAP) and \u03b1-l-iduronidase or acid \u03b1-glucosidase","volume":"279","author":"Prince","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2008.119_bib28","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1073\/pnas.0500062102","article-title":"Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent","volume":"102","author":"Bai","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.119_bib29","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/sj.mt.6300112","article-title":"Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation","volume":"15","author":"Ma","year":"2007","journal-title":"Mol Ther"},{"issue":"suppl. 1","key":"10.1038\/mt.2008.119_bib30","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/sj.gt.3302378","article-title":"Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development","volume":"11","author":"Gonin","year":"2004","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2008.119_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/mthe.2002.0630","article-title":"Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow","volume":"6","author":"Pan","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.119_bib32","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1089\/hum.2005.16.1133","article-title":"Gene therapy of storage disorders by retroviral and lentiviral vectors","volume":"16","author":"Biffi","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2008.119_bib33","doi-asserted-by":"crossref","first-page":"12873","DOI":"10.1073\/pnas.0705611104","article-title":"Epinephrine enhances lysosomal enzyme delivery across the blood brain barrier by up-regulation of the mannose 6-phosphate receptor","volume":"104","author":"Urayama","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.119_bib34","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1073\/pnas.0405042101","article-title":"Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier","volume":"101","author":"Urayama","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.119_bib35","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1089\/hum.2006.17.1112","article-title":"Limited transgene immune response and long-term expression of human \u03b1-l-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy","volume":"17","author":"Di Domenico","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2008.119_bib36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jgm.1028","article-title":"Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses","volume":"9","author":"Aronovich","year":"2007","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2008.119_bib37","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.mt.6300399","article-title":"Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation","volume":"16","author":"Chen","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.119_bib38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine \u03b1-l-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2008.119_bib39","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.gt.3302735","article-title":"Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice","volume":"13","author":"Watson","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2008.119_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0009-8981(79)90121-9","article-title":"A fluorometric assay using 4-methylumbelliferyl \u03b1-l-iduronide for the estimation of \u03b1-l-iduronidase activity and the detection of Hurler and Scheie syndromes","volume":"92","author":"Hopwood","year":"1979","journal-title":"Clin Chim Acta"},{"key":"10.1038\/mt.2008.119_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymthe.2004.08.027","article-title":"Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice","volume":"11","author":"Liu","year":"2005","journal-title":"Mol Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161632281X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161632281X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T01:17:02Z","timestamp":1708996622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500161632281X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S152500161632281X"],"URL":"https:\/\/doi.org\/10.1038\/mt.2008.119","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}